Get the Stockscreener App
319.90
0.24%
0.78
After Hours:
319.90
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Cencora Inc stock is traded at $319.90, with a volume of 1.08M.
It is up +0.24% in the last 24 hours and down -8.59% over the past month.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
See More
Previous Close:
$319.12
Open:
$318.33
24h Volume:
1.08M
Relative Volume:
0.82
Market Cap:
$62.23B
Revenue:
$325.78B
Net Income/Loss:
$1.64B
P/E Ratio:
38.48
EPS:
8.3139
Net Cash Flow:
$3.61B
1W Performance:
-0.31%
1M Performance:
-8.59%
6M Performance:
+0.62%
1Y Performance:
+12.53%
1-Day Range:
$316.33
$321.53
1-Week Range:
$314.51
$325.91
52-Week Range:
$271.00
$377.54
Cencora Inc Stock (COR) Company Profile
Name
Cencora Inc
Sector
Industry
Phone
610-727-7000
Address
1 WEST FIRST AVENUE, CONSHOHOCKEN
Compare COR vs MCK, CAH, HSIC, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
319.90 | 62.41B | 325.78B | 1.64B | 3.61B | 8.3139 |
MCK
Mckesson Corporation
|
862.79 | 106.03B | 397.96B | 4.55B | 9.64B | 34.77 |
CAH
Cardinal Health Inc
|
214.95 | 50.72B | 244.67B | 1.68B | 5.51B | 6.9487 |
HSIC
Henry Schein Inc
|
77.20 | 8.65B | 13.18B | 419.00M | 521.00M | 3.2704 |
AHG
Akso Health Group Adr
|
2.36 | 1.96B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-29-26 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jan-22-26 | Upgrade | Jefferies | Hold → Buy |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Jun-03-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-04-24 | Resumed | Mizuho | Outperform |
| Sep-18-24 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-14-23 | Initiated | Wells Fargo | Equal Weight |
| Mar-31-23 | Initiated | Citigroup | Buy |
| Jan-31-23 | Resumed | Evercore ISI | Outperform |
| Oct-11-22 | Upgrade | BofA Securities | Neutral → Buy |
| Aug-22-22 | Resumed | Morgan Stanley | Equal-Weight |
| Jul-11-22 | Downgrade | Evercore ISI | Outperform → In-line |
| Jun-07-22 | Upgrade | Deutsche Bank | Hold → Buy |
| May-26-22 | Upgrade | Barclays | Equal Weight → Overweight |
| Apr-12-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-12-21 | Resumed | Evercore ISI | In-line |
| Feb-04-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Feb-02-21 | Upgrade | Cowen | Market Perform → Outperform |
| Jan-06-21 | Upgrade | BofA Securities | Underperform → Neutral |
| Jan-06-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-10-20 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Dec-03-20 | Initiated | Mizuho | Neutral |
| Aug-06-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jul-15-20 | Initiated | Barclays | Underweight |
| Jun-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-23-20 | Resumed | Credit Suisse | Outperform |
| Apr-16-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-13-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-01-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-17-20 | Upgrade | Citigroup | Neutral → Buy |
| Feb-11-20 | Downgrade | BofA/Merrill | Buy → Underperform |
| Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Jul-10-19 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-11-19 | Initiated | Guggenheim | Buy |
| Apr-10-19 | Downgrade | BofA/Merrill | Buy → Underperform |
| Apr-10-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-11-19 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-17-19 | Initiated | UBS | Buy |
| Dec-10-18 | Downgrade | Jefferies | Buy → Hold |
| Oct-26-18 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-20-18 | Initiated | Berenberg | Buy |
| Jul-17-18 | Resumed | Stifel | Hold |
| Apr-09-18 | Initiated | MoffettNathanson | Buy |
| Mar-12-18 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
| Mar-12-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Sep-25-17 | Initiated | JP Morgan | Neutral |
| Sep-22-17 | Initiated | William Blair | Outperform |
View All
Cencora Inc Stock (COR) Latest News
Weekly Trades: Is Cencora Inc subject to activist investor interest2026 Historical Comparison & Risk Managed Investment Entry Signals - baoquankhu1.vn
Cencora sets May 6 date for second-quarter earnings release - MSN
All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside (NYSE:COR) - Seeking Alpha
Cencora Sets May 6 Date for Second-Quarter Earnings Release - MyChesCo
Patterns Watch: Can Cencora Inc outperform in the next rallyEarnings Risk Summary & Weekly Breakout Watchlists - baoquankhu1.vn
Cencora Tops Daily Turnover at $330 Million as Strategic Overhaul Meets Cautious Caution - Bitget
Assessing Cencora (COR) Valuation After Recent Share Price Weakness - simplywall.st
Cencora, Inc. (COR) signs binding agreement to expand retina network with EyeSouth acquisition - MSN
Is Cencora Inc stock a top performer YTD2026 Price Momentum & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Cencora to acquire EyeSouth retina business for $1.1 billion - MSN
Cencora Inc. stock rises Wednesday, still underperforms market - MarketWatch
Cencora (COR) Analyst Rating Update: Evercore ISI Group Lowers P - GuruFocus
Deals tracker: Orlando Health to acquire Alabama health system - Modern Healthcare
Evercore ISI Adjusts Price Target on Cencora to $360 From $420, Maintains Outperform Rating - marketscreener.com
Is Cencora (COR) Pricing Reflect Its DCF Value After Recent Healthcare Supply Chain Scrutiny - simplywall.st
Daytona Street Capital LLC Takes Position in Cencora, Inc. $COR - MarketBeat
Here's Why You Should Hold Cencora Stock in Your Portfolio Now - MSN
Cencora CFO James Cleary to retire June 30, 2026 - MSN
Cencora to Acquire EyeSouth Retina Business for $1.1 Billion - MyChesCo
Cencora Inc. stock underperforms Monday when compared to competitors - MarketWatch
Cencora, Inc. (COR) Stock forecasts - uk.finance.yahoo.com
Cencora Expands Retina Network As CFO Retirement Opens New Chapter - simplywall.st
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
HF Advisory Group LLC Boosts Stock Holdings in Cencora, Inc. $COR - MarketBeat
Cencora to Announce Fourth Quarter Fiscal 2025 Results on November 5 - MSN
Cencora (COR) SVP & CAO receives 3,936 restricted stock units - Stock Titan
Cencora Inc. Stock: Institutional Buying Signals Strength in Pharmaceutical Distribution Leader Amid - AD HOC NEWS
Press Release: Cencora Announces Date and Time for Second Quarter Fiscal 2026 Earnings Release - Moomoo
Cencora, Inc. (COR) Options Chain - Yahoo! Finance Canada
Cencora Announces Date and Time for Second Quarter Fiscal 2026 Earnings Release - marketscreener.com
Cencora CFO James Cleary to Retire June 30, 2026 - MyChesCo
Nisa Investment Advisors LLC Acquires 27,857 Shares of Cencora, Inc. $COR - MarketBeat
Bourgeon Capital Management LLC Invests $2.74 Million in Cencora, Inc. $COR - MarketBeat
Cencora will post quarterly results before the market opens May 6 - Stock Titan
Cencora Inc. stock rises Tuesday, still underperforms market - MarketWatch
Spire Wealth Management Raises Stock Position in Cencora, Inc. $COR - MarketBeat
Allspring Global Investments Holdings LLC Sells 40,638 Shares of Cencora, Inc. $COR - MarketBeat
Assessing Cencora (COR) Valuation After Recent Share Price Weakness And Premium P/E Ratio - simplywall.st
Cencora, Inc. (COR) Signs Binding Agreement to Expand Retina Network With EyeSouth Acquisition - Insider Monkey
Donaldson Capital Management LLC Has $46.31 Million Stock Holdings in Cencora, Inc. $COR - MarketBeat
Cencora, Inc. $COR Shares Sold by Wedge Capital Management L L P NC - MarketBeat
Cencora, Inc. $COR Shares Sold by Waycross Partners LLC - MarketBeat
Cencora Inc. stock outperforms competitors despite losses on the day - MarketWatch
6,960 Shares in Cencora, Inc. $COR Acquired by Global X Japan Co. Ltd. - MarketBeat
Cencora Inc Stock (COR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.36%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):